British-Swedish AstraZeneca was said to have sold its shares in the American biotech company Moderna for more than $ 1 billion. The sale came after Moderna announced the 94 percent effective mRNA vaccine.
However, the exact time of the sale has not been disclosed.
AstraZenaca owned 7.7 percent of Moderna’s shares, making it the second largest investor in Moderna last year.
WILL BE USED TO PURCHASE ALEXION
However, it is claimed that AstraZeneca will use the cash obtained from the sale of Moderna shares, estimated to be about $ 1.2 billion, to complete the $ 39 billion purchase of Alexion from the US, which develops drugs. for rare diseases. .
AstraZeneca continues its partnership with Moderna on other disease treatments, and it is stated that if the virus becomes endemic, the Oxford / AstraZeneca vaccine may be co-sold commercially in the future. The viral vector vaccine, which has an average efficacy of 70 percent, is currently distributed on a non-profit basis.
On the other hand, Moderna announced last week that it expected an income of $ 18.4 billion from the corona virus vaccine it produced this year.
ELDERLY PASSED TO GET A VACCINE